Synonyms: Braftovi® | LGX-818 | LGX818
encorafenib is an approved drug (FDA and EMA (2018))
Compound class:
Synthetic organic
Comment: Encorafenib (LGX-818) is an orally available BRAF kinase inhibitor with antineoplastic activity.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2018) | EMA (2018) |
IUPAC Name ![]() |
methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate |
International Nonproprietary Names ![]() |
|
INN number | INN |
9816 | encorafenib |
Synonyms ![]() |
Braftovi® | LGX-818 | LGX818 |
Database Links ![]() |
|
Specialist databases | |
Reactome Drug
![]() |
R-ALL-9657027 |
Reactome Reaction
![]() |
R-HSA-6802938 |
Other databases | |
CAS Registry No. | 1269440-17-6 |
ChEMBL Ligand | CHEMBL3301612 |
DrugCentral Ligand | 5289 |
GtoPdb PubChem SID | 249565591 |
PubChem CID | 50922675 |
Search Google for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
Search Google for chemicals with the same backbone | CMJCXYNUCSMDBY |
Search PubMed clinical trials | encorafenib |
Search PubMed titles | encorafenib |
Search PubMed titles/abstracts | encorafenib |
UniChem Compound Search for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
Wikipedia | LGX818 |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Encorafenib (links to external site)
Cat. No. HY-15605 |